ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-050)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01824238
Recruitment Status : Completed
First Posted : April 4, 2013
Last Update Posted : April 25, 2016
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.